Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

April 29, 2016

Milford company scales back IPO to $15M

Courtesy

Spring Bank Pharmaceuticals, an early-stage biotech that develops targeted therapies for viral diseases, is going for a scaled back version of its initial public offering.

The Milford-based company plans to offer an initial 1.2 million shares priced between $12 and $14, according to IPO advising organization Renaissance Capital. This is a scaled back version of the IPO that Spring Bank was seeking in March and postponed. That initial IPO sought $40 million in funding with the intent of selling approximately 2.8 million shares.

Spring Bank Pharmaceuticals was founded in 2002 and will be listed on the Nasdaq under the symbol SBPH.

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF